Skip to main content
SpringerLink
Log in
Book cover

Drugs for the Treatment of Parkinson’s Disease pp 227–270Cite as

The Relationship Between Parkinson’s Disease and Other Movement Disorders

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 88))

Abstract

Parkinson’s disease, a specific clinical-pathologic entity, is one of the commonest causes of disability among the elderly. The prevalence figures for Parkinson’s disease vary considerably among the different epidemiologic studies. A door-to-door survey in a biracial population of Copiah County, Mississippi revealed a prevalence of 347 per 100 000 inhabitants (Schoenberg et al. 1985). The prevalence in a population over the age of 65, however, is about 1%. Although previous studies suggested a higher frequency of Parkinson’s disease among males and whites, this epidemiologic survey found no substantial differences in the age-adjusted prevalence ratios by race or by sex. Over 40% of the identified cases were not diagnosed until this door-to-door survey. Thus, it is possible that for every two patients diagnosed as having Parkinson’s disease there is one patient whose symptoms may not be disabling enough to warrant medical attention. Furthermore, the diagnosis is often missed in the early stages of the disease and the symptoms may be incorrectly attributed to a variety of other problems. Therefore, the variability in reported prevalence figures can be partly explained by differences in the methods of ascertainment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams RDL, van Bogaert, Van der Eecken H (1964) Striatonigral degeneration. J Neuropathol Exp Neurol 23: 584–608

    PubMed  CAS  Google Scholar 

  • Allen JM, Cross AJ, Yeats JL et al. (1986) Neuropeptides and dopamine in the marmoset: effect of treatment with l-methyl-4-phenyl-l,2,3,6-tetrohydropyridine (MPTP): an animal model for Parkinson’s disease. Brain 109: 143–158

    PubMed  Google Scholar 

  • Alonso MA, Otero E, D’Regules R, Figueroa M (1986) Parkinson’s disease: a genetic study. Can J Neurol Sci 13: 248–251

    PubMed  CAS  Google Scholar 

  • Antunes JL, Fahn S, Cote L (1983) Normal pressure hydrocephalus and Parkinson’s disease. J Neurol Transm [Suppl] 19: 225–231

    Google Scholar 

  • Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer’s disease. Ann Neurol 10: 499–505

    PubMed  CAS  Google Scholar 

  • Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to l-methyl-4-phenyl-l,2,3,6-tetrohydropyridine (MPTP): seven cases. Neurology (NY) 35: 949–956

    CAS  Google Scholar 

  • Bannister R, Oppenheimer D (1981) Parkinsonism, system degenerations and autonomic failure. In: Marsden CD, Fahn S (eds) Movement Disorders. Butterworth, London, pp 174–190

    Google Scholar 

  • Banta RG, Markesbery WR (1977) Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology (NY) 27: 213–216

    CAS  Google Scholar 

  • Barbeau A, Roy M (1984) Familial subsets in idiopathic Parkinson’s disease. Can J Neurol Sci 11: 144–150

    PubMed  CAS  Google Scholar 

  • Barbeau A, Cloutier T, Roy M et al. (1985) Exogenetics of Parkinson’s disease: 4-hydroxylation of debrisoquine. Lancet 2: 1213–1216

    PubMed  CAS  Google Scholar 

  • Beall S, Patten BM, Jankovic J (1984) Familial calcifications of the brain, iron storage, and porphyria: a new syndrome. Ann Neurol 16: 137

    Google Scholar 

  • Berciano J (1987) Olivopontocerebellar atrophies. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movement disorders. Urban and Schwarzenberg, Baltimore (in press)

    Google Scholar 

  • Berger JR, Ross DB (1981) Reversible Parkinson syndrome complicating postoperative hypoparathyroidism. Neurology (NY) 31: 881–882

    CAS  Google Scholar 

  • Berger L, Gauthier S, Le Blanc R (1985) Akinetic mutism and parkinsonism associated with obstructive hydrocephalus. Can J Neurol Sci 12: 255–258

    PubMed  CAS  Google Scholar 

  • Biemond A, Sinnege JLM (1955) Tales of Friedreich with degeneration of the substantia nigra, a special type of hereditary parkinsonism. Confin Neurol 15: 129–145

    PubMed  CAS  Google Scholar 

  • Bird ED, Anton AH (1982) Phenothiazine biphasic effect on dopamine concentrations in the basal ganglia of subhuman primates. Psychiatry Res 6: 1–6

    PubMed  CAS  Google Scholar 

  • Bird ED, Collins GH, Dodson MH, Grant LG (1967) The effect of phenothiazine on the manganese concentration in the basal ganglia of subhuman primates. In: Barbeau A, Brunette J A (eds) Progress in neurogenetics, vol 1. Excerpta Medica, Amsterdam, pp 600–605

    Google Scholar 

  • Bird ED, Anton AH, Bullock B (1984) The effect of manganese inhalation of basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology (Park Forest II ) 5: 59–66

    CAS  Google Scholar 

  • Bladin PF, Berkovic SF (1984) Striatocapsular infarction: large infarcts in the lenticulostriate arterial territory. Neurology (NY) 34: 1423–1430

    CAS  Google Scholar 

  • Blanc P, Hogan M, Mallin K et al. (1985). Cyanide intoxication among silver-reclaiming workers. JAMA J 253: 367–371

    CAS  Google Scholar 

  • Bockman JM, Kingsbury DT, Mc Kinley MP et al. (1985) Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med 312: 73–78

    PubMed  CAS  Google Scholar 

  • Boller F, Boller M, Gilbert J (1977) Familial idiopathic cerebral calcifications. J Neurol Neurosurg Psychiatry 40: 280–285

    PubMed  CAS  Google Scholar 

  • Brown P, Gajdusek DC, Gibbs CJ, Asmer DM (1985) Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313: 728–731

    PubMed  CAS  Google Scholar 

  • Brown P, Cathala F, Castaigne P, Gajdusek DC (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20: 597–602

    PubMed  CAS  Google Scholar 

  • Calne DB, Eisen A, Mc Geer E, Spencer P (1986) Alzheimer’s disease, Parkinson’s disease, and motoneuron disease: abiotropic interaction between aging and environment. Lancet 2: 1067–1070

    PubMed  CAS  Google Scholar 

  • Calne DB, Lees AJ (1988) Late progression of post-encephalitic Parkinson’s syndrome. Can J Neurol Sci 15: 135–138

    PubMed  CAS  Google Scholar 

  • Carlen PL, Lee MA, Jacob M, Livshits O (1981) Parkinsonism provoked by alcoholism. Ann Neurol 9: 84–86

    PubMed  CAS  Google Scholar 

  • Choi HS (1983) Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 40: 433–435

    PubMed  CAS  Google Scholar 

  • Chokroverty S, Khedekar R, Derby B et al. (1984) Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiency. Neurology (NY) 34: 1451–1455

    CAS  Google Scholar 

  • Chui HC, Mortimer JA, Slager U et al. (1986) Pathologic correlates of dementia in Parkinson’s disease. Arch Neurol 43: 991–995

    PubMed  CAS  Google Scholar 

  • Clough CG, Mendoza M, Yahr MD (1981) A case of sporadic juvenile Parkinson’s disease. Arch Neurol 38: 730–731

    PubMed  CAS  Google Scholar 

  • Cohen G (1984) Oxyradical toxicity in catecholamine neurons. Neurotoxicology (Park Forest II ) 5: 77–82

    CAS  Google Scholar 

  • Critchley M (1929) Arteriosclerotic parkinsonism. Brain 52: 23–83

    Google Scholar 

  • D’Antona R, Baron JC, Samson Y, Serdary M et al. (1985) Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain 108: 785–799

    PubMed  Google Scholar 

  • Davis PH, Bergeron C, Mc Lachlan DR (1985) Atypical presentation of progressive supranuclear palsy. Ann Neurol 17: 337–343

    PubMed  CAS  Google Scholar 

  • Dickson DW, Kress Y, Crowe A, Yen SH (1985) Monoclonal antibodies in Alzheimer neurofibrillary tanges. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am J Pathol 120: 292–303

    PubMed  CAS  Google Scholar 

  • Donaldson J, La Bella FS, Gesser D (1980) Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology (Park Forest II ) 2: 53–64

    Google Scholar 

  • Dubinsky RM, Jankovic J (1987) Progressive supranuclear palsy and a multi-infarct state. Neurology (NY) 37: 570–576

    CAS  Google Scholar 

  • Earnest MP, Fahn S, Karp JH, Rowland LP (1974) Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Arch Neurol 31: 262–266

    PubMed  CAS  Google Scholar 

  • Editorial (1981) Encephalitis lethargica. Lancet 2: 1396–1397

    Google Scholar 

  • Eidelberg D, Sotrel A, Joachim C, Selkoe D, et al. (1987) Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. Brain 110: 993–1013

    PubMed  Google Scholar 

  • Elizan TS, Terasake PI, Yahr MD (1980) HLA-B14 antigen and postencephalitic Parkinson’s disease. Arch Neurol 37: 542–544

    PubMed  CAS  Google Scholar 

  • Elizan TS, Sroka H, Maker H et al. (1986) Dementia in idiopathic Parkinson’s disease. Variables associated with its occurrence in 203 patients. J Neurol Transm 65: 285–302

    CAS  Google Scholar 

  • Evans BK, Donley DK (1988) Pseudohypoparathyroidism, Parkinsonism syndrome, with no basal ganglia calcification. J Neurol Neurosurg Psychiatry 51: 709–713

    PubMed  CAS  Google Scholar 

  • Fahn S (1977) Secondary parkinsonism. In: Goldensohn ES, Appel SH (eds) Shy’s cellular and molecular basis of neurologic disease. Lea and Febiger, Philadelphia, pp 1159–1189

    Google Scholar 

  • Farrell DF, Starr A (1968) Delayed neurological sequelae of electrical injuries. Neurology (NY) 18: 601–608

    CAS  Google Scholar 

  • Ferraz HB, Bertolucci PHF, Pereira JS, Lima JGC, Andrade LAF (1988) Chemie exposure to the funcicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38: 550–553

    PubMed  CAS  Google Scholar 

  • Findley LJ, Gresty MA (1984) Tremor and rhythmical involuntary movements in Parkinson’s disease. In: Findley LJ, Capildeo R (eds) Movement disorders: tremor. Oxford University Press, New York, pp 295–304

    Google Scholar 

  • Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104: 79–95

    PubMed  CAS  Google Scholar 

  • Fitzgerald P, Jankovic J. Lower body parkinsonism: Evidence for vascular etiology. Movement Disorders (in press)

    Google Scholar 

  • Forno LS, Langston JW, De Lanney LE et al. (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20: 449–455

    PubMed  CAS  Google Scholar 

  • Fournier JG, Tardieu M, Lebon P et al. (1985) Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med 313: 910–915

    PubMed  CAS  Google Scholar 

  • Friedman A, Kang UJ, Tatemichi TK, Burke RE (1986). A case of parkinsonism following striatal lacunar infarction. J Neurol Neurosurg Psychiatry 49: 1087–1088

    PubMed  CAS  Google Scholar 

  • Funkenstein HH, Miller DC (1985) Case records of the Massachusetts General Hospital. Case 38-195. N Engl J Med 313: 739–748

    Google Scholar 

  • Gajdusek DC (1985) Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system. N Engl J Med 312: 714–719

    PubMed  CAS  Google Scholar 

  • Galassi G, Nemni R, Babaldi A et al. (1982) Peripheral neuropathy in multiple system atrophy with autonomic failure. Neurology (NY) 32: 1116–1121

    CAS  Google Scholar 

  • Gamboa ET, Wolf A, Yahr MD et al. (1974) Influenza virus antigen in postencephalitic parkinsonism brain: detection by immunofluorescence. Arch Neurol 31: 228–232

    PubMed  CAS  Google Scholar 

  • Garruto RM, Yase Y (1986) Neurodegenerative disorders of the western Pacific: the search for mechanisms of pathogenesis. Trends Neurosci 9: 368–374

    Google Scholar 

  • Garruto RM, Yanagihara R, Gajdusek DC (1985) Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology (NY) 35: 193–198

    CAS  Google Scholar 

  • Garruto RM, Yanagihara R, Gajdusek DC (1988) Cycades and amyotrophic lateral sclerosis/parkinsonism dementia. Lancet 2: 1079

    PubMed  CAS  Google Scholar 

  • Geraghty JJ, Jankovic J, Zetusky WJ (1985) Association between essential tremor and Parkinson’s disease. Ann Neurol 17: 329–333

    PubMed  CAS  Google Scholar 

  • Gerard G, Weisberg LA (1986) MRI periventricular lesions in adults. Neurology (NY) 36: 998–1001

    CAS  Google Scholar 

  • Gershanik OS, Leist A (1987) Juvenile onset Parkinson’s disease. In: Bergmann KJ, Yahr MD (eds) Parkinson’s disease. Raven, New York, pp 213–216

    Google Scholar 

  • Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain (in press)

    Google Scholar 

  • Glatt S, Fine S, Kaplan J (1983) Parkinsonism as a presentation of subdural hematoma. Neurology (NY) 33 (Suppl 2): 61

    Google Scholar 

  • Goetz CG, Klawans HL, Cohen MM (1981) Neurotoxic agents. In: Baker AB, Joynt RJ (eds), Clinical neurology, Harper and Row, Philadelphia, chap 20, pp 1–84

    Google Scholar 

  • Goetz CG, Tanner CM, Levy M et al. (1986) Pain in Parkinson’s disease. Movement disorders 1: 45–49

    PubMed  CAS  Google Scholar 

  • Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC (1988) Prevalence and natural history of progressive supranuclear palsy. Neurology 38: 1031–1034

    PubMed  CAS  Google Scholar 

  • Graves MC (1984) Subacute sclerosing panencephalitis. Neurol Clin 2: 267–280

    PubMed  CAS  Google Scholar 

  • Greenhouse AH (1982) Heavy metals and the nervous system. Clin Neuropharmacol 5: 45–92

    PubMed  CAS  Google Scholar 

  • Greenough A, Davis JA (1983) Encephalitis lethargica: mystery of the past or undiagnosed disease of the present? Lancet 1: 922–923

    PubMed  CAS  Google Scholar 

  • Grimberg L (1934) Paralysis agitans and trauma. J Nerv Ment Dis 79: 14–20

    Google Scholar 

  • Harati Y, Jackson JA, Benjamin E (1984) Adult onset idiopathic familial brain calcifications. Arch Intern Med 144: 2425–2427

    PubMed  CAS  Google Scholar 

  • Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson’s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51: 850–854

    PubMed  CAS  Google Scholar 

  • Harding AE (1986) Degenerative ataxic disorders. Trends Neurosci 9: 311–313

    Google Scholar 

  • Hardy RL, Stevenson LD (1957) Syringomesencephalia: report of a case with signs of Parkinson’s disease having a syrinx of the substantia nigra. J Neuropathol Exp Neurol 16: 365–369

    PubMed  CAS  Google Scholar 

  • Harrington M, Merril CR, Asher DM, Gajdusek DC (1986) Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 315: 279–283

    PubMed  CAS  Google Scholar 

  • Hassan M, Reches A, Kuhn C et al. (1986) Pharmacologic evaluation of dopaminergic receptor blockage by metoclopramide. Clin Neuropharmacol 9: 71–78

    PubMed  CAS  Google Scholar 

  • Hayden MR, Hewitt J, Stoessel AJ, et al. (1987) The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington’s disease. Neurology (NY) 37: 1441–1447

    CAS  Google Scholar 

  • Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology (NY) 36: 698–702

    CAS  Google Scholar 

  • Howard RS, Lees AJ (1987) Encephalitis lethargica. A report of 4 cases. Brain 110: 19–34

    PubMed  Google Scholar 

  • Hudson AJ (1981) Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 104: 217–247

    PubMed  CAS  Google Scholar 

  • Hurst EW (1972) Experimental demyelination of the central nervous system. 3. Poisoning with potassium cyanide, sodium azide, hydroxylamine, narcotics, carbon monoxide with some consideration of bilateral necrosis occurring in the basal ganglia. Aust J Exp Biol Med Sci 20: 297–342

    Google Scholar 

  • Indo T, Ando K (1982) Metoclopramide-induced parkinsonism. Clinical characteristics of ten cases. Arch Neurol 39: 494–496

    PubMed  CAS  Google Scholar 

  • Iqbal K, Zaidi T, Weng Y et al. (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet 2: 421–426

    PubMed  CAS  Google Scholar 

  • Jackson DL, Menges H (1980) Accidental carbon monoxide poisoning. JAMA 243: 772–774

    PubMed  CAS  Google Scholar 

  • Jackson J, Jankovic J, Ford J (1983) Progressive supranuclear palsy: clinical features and response to treatment in sixteen patients. Ann Neurol 13: 273–278

    PubMed  CAS  Google Scholar 

  • Jankovic J (1981) Drug-induced and other orofacial-cervical dyskinesias. Ann Intern Med 94: 788–793

    PubMed  CAS  Google Scholar 

  • Jankovic J (1983) Controlled trial of pergolide mesylate in Parkinson’s disease and progressive supranuclear palsy. Neurology (NY) 33: 505–507.

    CAS  Google Scholar 

  • Kish SJ, Chang LJ, Mirchandana L et al. (1985) Progressive supranuclear palsy: relationships between extrapyramidal disturbances, dementia and brain neurotransmitter markers. Ann Neurol 18: 530–536

    PubMed  CAS  Google Scholar 

  • Kitamoto T, Tateishi J, Tashima T et al. (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol 20: 204–208

    PubMed  CAS  Google Scholar 

  • Klawans HL (1981) Hemiparkinsonism as a late complication of hemiatrophy: a new syndrome. Neurology (NY) 31: 625–628

    CAS  Google Scholar 

  • Klawans HL, Bergen D, Bruyn GW (1973) Prolonged drug-induced parkinsonism. Confln Neurol 35: 368–377

    Google Scholar 

  • Klawans HL, Lupton M, Simon L (1976) Calcification of the basal ganglia as a cause of levodopa-resistant parkinsonism. Neurology (NY) 26: 221–225

    CAS  Google Scholar 

  • Klawans HL, Stein RW, Tanner CM, Goetz CG (1982) A pure parkinsonian syndrome following acute carbon monoxide intoxication. Arch Neurol 39: 302–304

    PubMed  CAS  Google Scholar 

  • Knutsson E, Lying-Tunnell U (1985) Gait apraxia in normal-pressure hydrocephalus: patterns of movement and muscle activation. Neurology (NY) 35: 155–160

    CAS  Google Scholar 

  • Koeppen AH, Mitzen EJ, Hans MB, Barron KD (1986) Olivopontocerebellar atrophy: immunocytochemical and Golgi observations. Neurology (NY) 36: 1478–1488

    CAS  Google Scholar 

  • Koller WC (1984) The diagnosis of Parkinson’s disease. Arch Intern Med 144: 2146–2147

    PubMed  CAS  Google Scholar 

  • Koller WC, Cochran JW, Klawans HL (1979) Calcification of the basal ganglia: computerized tomography and clinical correlation. Neurology (NY) 29: 328–333

    CAS  Google Scholar 

  • Konigsmark BW, Weiner LP (1970) The olivopontocerebellar atrophies: a review. Medicine 49: 227–241

    PubMed  CAS  Google Scholar 

  • Kosaka K, Matsushita M, Oyanagi S et al. (1981) Pallido-nigral-luysial atrophy with massive appearance of corpora amylacea in the CNS. Acta Neuropathol (Berl) 53: 169–172

    CAS  Google Scholar 

  • Kristensen MO (1985) Progressive supranuclear palsy—20 years later. Acta Neurol Scand 71: 177–189

    PubMed  CAS  Google Scholar 

  • Krusz JC, Koller WC, Ziegler DK (1987) Historial review: abnormal movements associated with epidemic encephalitis lethargica. Movement Disorders 2: 137–141

    PubMed  CAS  Google Scholar 

  • Lang AE, Marsden CD, Obeso JA, Parkes JD (1982) Alcohol and Parkinson disease. Ann Neurol 12: 254–256

    PubMed  CAS  Google Scholar 

  • Lang AE, Birnbaum A, Blair RDG, Kierans C (1986) Levodopa dose-related fluctuations in presumed olivopontocerebellar atrophy. Movement Disorders 1: 93–112

    PubMed  CAS  Google Scholar 

  • Langston JW, Irwin I (1986) MPTP: current concepts and controversies. Clin Neuropharmacol 9: 485–507

    PubMed  CAS  Google Scholar 

  • LaPorte JR, Capella D (1986) Useless drugs are not placebos: lessons from flunarizine and cinnarizine. Lancet 2: 853–854

    PubMed  CAS  Google Scholar 

  • Lima B, Neves G, Nora M (1987) Juvenile parkinsonism: clinical and metabolic characteristics. J Neurol Neurosurg Psychiatry 50: 345–348

    PubMed  CAS  Google Scholar 

  • Lepore FE, Duvoisin RC (1985) Apraxia of eyelid opening: an involuntary levator inhibition. Neurology (NY) 35: 423–427

    CAS  Google Scholar 

  • Lewy FH (1941) Neurological, medical and biochemical signs and symptoms indicating chronic industrial carbon disulfide absorption. Ann Intern Med 15: 869–878

    Google Scholar 

  • Magos L, Jarvis JAE (1970) The effect of carbon disulfide exposure on brain catecholamines in rats. Br J Pharmacol 39: 26–33

    PubMed  CAS  Google Scholar 

  • Mäher ER, Lees AJ (1986) The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (NY) 36: 1005–1008

    Google Scholar 

  • Manuelidis EL (1985) Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 44: 1–17

    PubMed  CAS  Google Scholar 

  • Manyam BV (1986) Recent advances in the treatment of cerebellar ataxias. Clin Neuropharmacol 9: 508–516

    PubMed  CAS  Google Scholar 

  • Martin JB, Gusella JF (1986) Huntington’s disease. Pathogenesis and management. N Engl J Med 315: 1267–1276

    PubMed  CAS  Google Scholar 

  • Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease. Clinical analysis of 100 patients. Neurology (NY) 23: 783–790

    CAS  Google Scholar 

  • Marttila RJ, Rinne UK (1976) Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson’s disease. Clin Neurol Neurosurg 79: 46–56

    PubMed  CAS  Google Scholar 

  • Marttila RJ, Rinne UK, Halonen P et al. (1981) Herpes viruses and parkinsonism. Herpes simplex virus type 1 and 2, and cytomegalovirus antibodies in serum and CSF. Arch Neurol 38: 19–21

    PubMed  CAS  Google Scholar 

  • Mata M, Dorovini-Zis K, Wilson M, Young AB (1983) New form of familial Parkinson-dementia syndrome: clinical and pathologic findings. Neurology (NY) 33: 1439–1443

    CAS  Google Scholar 

  • Mayeux R (1984) Behavioral manifestations of movement disorders. Parkinson’s and Huntington’s disease. In: Jankovic J (ed) Neurologic clinic, vol 2. Saunders, Philadelphia, pp 527–540

    Google Scholar 

  • Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology (NY) 35: 453–461

    CAS  Google Scholar 

  • Mayo J, Arias M, Leno C, Berciano J (1986) Vascular parkinsonism and periarteritis nodosa. Neurology (NY) 36: 874–875

    CAS  Google Scholar 

  • Mena I, Marin O, Fuenzalida S, Cotzias G (1967) Chronic manganese poisoning: clinical picture and manganese turnover. Neurology (NY) 17: 128–136

    CAS  Google Scholar 

  • Micheli F, Pardal MF, Gatto M, et al. (1987) Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology (NY) 37: 881–884

    CAS  Google Scholar 

  • Molsa PK, Marttila RJ, Rinne UK (1984) Extrapyramidal signs in Alzheimer’s disease. Neurology (NY) 34: 1114–1116

    CAS  Google Scholar 

  • Muenter MD, Whisnant JP (1968) Basal ganglia calcification, hypoparathyroidism and extrapyramidal motor manifestations. Neurology (NY) 18: 1075–1083

    CAS  Google Scholar 

  • Murphy MJ (1979) Clinical correlations of CT scan-detected calcifications of the basal ganglia. Ann Neurol 6: 507–511

    PubMed  CAS  Google Scholar 

  • Naidu S, Wolfson LI, Sharpless NS (1978) Juvenile parkinsonism: a patient with possible primary striatal dysfunction Ann Neurol 3: 453–455

    CAS  Google Scholar 

  • Nath A, Jankovic J, Pettigrew LC (1987) Movement disorders and AIDS. Neurology (NY) 37: 37–41

    CAS  Google Scholar 

  • Newman GC (1985) Treatment of progressive supranuclear palsy with tricyclic antidepressants. Neurology (NY) 35: 1189–1193

    CAS  Google Scholar 

  • Newman RP, Le Witt PA, Jaffe M, Calne DB, Larsen TA (1985) Motor function in the normal aging population: treatment with levodopa. Neurology (NY) 35: 571–573

    CAS  Google Scholar 

  • Nicholson AN, Turner EA (1964) Parkinsonism produced by parasagittal meningiomas. J Neurosurg 21: 104–113

    PubMed  CAS  Google Scholar 

  • Nygaard TG, Duvoisin RC (1986) Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology (NY) 36: 1424–1428

    CAS  Google Scholar 

  • Ohta K, Tsuji S, Mizuno Y et al. (1985) Type 3 (adult) GM1 gangliosidosis: case report. Neurology (NY) 35: 1490–1494

    CAS  Google Scholar 

  • Olson CG, Hogstedt C (1981) Parkinson’s disease and occupational exposure to organic solvents, agricultural chemicals and mercury—a case referent study. Scand J Work Environ Health 7: 252–256

    Google Scholar 

  • Parkes JD, Marsden CD, Rees JE et al. (1974) Parkinson’s disease, cerebral arteriosclerosis, and senile dementia: clinical features and response to levodopa. Q J Med 93: 49–61

    Google Scholar 

  • Patten BM (1988) Wilson’s disease. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movement disorders. Urban and Schwarzenberg, Baltimore, pp 179–190

    Google Scholar 

  • Perry TL, Norman MG, Yong VW et al. (1985) Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 18: 482–489

    PubMed  CAS  Google Scholar 

  • Peters HL, Levin RL, Matthews CG, Chapman LJ (1988) Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 45: 537–540

    PubMed  CAS  Google Scholar 

  • Polinsky RJ (1988) Shy-Drager syndrome. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movement disorders. Urban and Schwarzenberg, Baltimore, pp 153–166

    Google Scholar 

  • Pollock NJ, Mirra SS, Binder LI et al. (1986) Filamentous aggregates in Pick’s disease, progressive supranuclear palsy, and Alzheimer’s disease share antigenic determinants with microtubule-associated protein, tau. Lancet 2: 1211

    PubMed  CAS  Google Scholar 

  • Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson’s syndrome. Evidence for a single etiology related to subclinical infection about 1920. J Chronic Dis 16: 961–972

    PubMed  CAS  Google Scholar 

  • Purdon-Martin J (1967) The basal ganglia and posture. Lippincott, Philadelphia

    Google Scholar 

  • Quinn N, Critchley P, Marsden CD (1987) Young onset Parkinson’s disease. Movement Disorders 2: 73–91

    PubMed  CAS  Google Scholar 

  • Rafal RD, Friedman JH (1987) Limb dystonia in progressive supranuclear palsy. Neurology (NY) 37: 1546–1549

    CAS  Google Scholar 

  • Rail D, Scholtz C, Swash M (1981) Post-encephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry 44: 670–676

    PubMed  CAS  Google Scholar 

  • Rajput AH, Kazi KH, Rozdilsky B (1972) Striatonigral degeneration: response to levodopa therapy. J Neurol Sci 16: 331–341

    PubMed  CAS  Google Scholar 

  • Rajput A, Rozdilsky B, Hornykiewicz O et al. (1982) Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol 39: 644–646

    PubMed  CAS  Google Scholar 

  • Rasker JJ, Jansen ENG, Haan J, Oostrom J (1985) Normal-pressure hydrocephalus in rheumatic patients. A diagnostic pitfall. N Engl J Med 312: 1239–1241

    PubMed  CAS  Google Scholar 

  • Ravenholt RT, Foege WH (1982) 1918 Influenza, encephalitis lethargica, parkinsonism. Lancet 2: 860–864

    PubMed  CAS  Google Scholar 

  • Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33

    PubMed  CAS  Google Scholar 

  • Reches A, Tietler J, Lavy S (1981) Parkinsonism due to lithium carbonate poisoning. Arch Neurol 38: 471

    PubMed  CAS  Google Scholar 

  • Richardson EP (1986) Parkinson’s disease. Ann Neurol 20: 447–448

    PubMed  Google Scholar 

  • Richter R (1945) Degeneration of the basal ganglia in monkeys from chronic carbon disulfide poisoning. J Neuropathol Exp Neurol 4: 324–330

    PubMed  CAS  Google Scholar 

  • Robbins JA, Logemann JA, Kirshner HS (1986) Swallowing and speech production in Parkinson’s disease. Ann Neurol 19: 283–287

    PubMed  CAS  Google Scholar 

  • Roberts GW, Brown P, Crow TJ et al. (1986) Prion-protein immunoreactivity in human transmittable dementias. N Engl J Med 315: 1231–1233

    CAS  Google Scholar 

  • Ropper AH (1983) Case records of the Massachusetts General Hospital. Case 23-1983. N Engl J Med 308: 1406–1414

    Google Scholar 

  • Rosenberg RN (1984) Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol 41: 179–193

    PubMed  CAS  Google Scholar 

  • Royden-Jones H, Hedley-Whyte T, Freidberg SR, Baker AA (1985) Ataxic Creutzfeldt-Jakob disease: diagnostic techniques and neuropathologic observations in early disease. Neurology (NY) 35: 254–257

    Google Scholar 

  • Ruberg M, Javoy-Agid F, Hirsch E et al. (1985) Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol 18: 523–529

    PubMed  CAS  Google Scholar 

  • Samples JR, Howard FM, Okazake H (1983) Syringomesencephalia. Report of a case. Arch Neurol 40: 757–759

    PubMed  CAS  Google Scholar 

  • Sandyk R (1985) Parkinsonism induced by captopril, Clin Neuropharmacol 8: 197–200

    PubMed  CAS  Google Scholar 

  • Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology (NY) 36: 1130–1133

    CAS  Google Scholar 

  • Sawada Y, Sakamoto T, Nishide K, et al. (1983) Correlation of pathological findings with CT findings after acute carbon monoxide poisoning. N Engl J Med 308: 1296

    PubMed  CAS  Google Scholar 

  • Scheinberg IH, Sternlieb I (1984) Wilson’s disease. Saunders, Philadelphia, pp 1–171

    Google Scholar 

  • Schmitt HP, Emser W, Heimes C (1984) Familial occurrence of amyotrophic lateral sclerosis, parkinsonism and dementia. Ann Neurol 16: 642–648

    PubMed  CAS  Google Scholar 

  • Schoenberg BS, Anderson DW, Haerer AF (1985) Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology (NY) 35: 841–845

    CAS  Google Scholar 

  • Schott GD (1986) Induction of involuntary movements by peripheral trauma: an analogy with causalgia. Lancet 2: 712–716

    PubMed  CAS  Google Scholar 

  • Schwab RS, England AC (1968) Parkinson syndrome due to various specific causes. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 6. North-Holland, Amsterdam, pp 227–247

    Google Scholar 

  • Sciarra D, Sprofkin B (1953) Symptoms and signs referable to the basal ganglia in brain tumor. Arch Neurol Psychiatry 69: 450–461

    CAS  Google Scholar 

  • Serratrice GT, Toga M, Pellissier JF (1983) Chronic spinal muscular atrophy and pallidonigral degeneration: report of a case. Neurology (NY) 33: 306–310

    CAS  Google Scholar 

  • Sharpe JA, Rewcastle NB, Lloyd KG et al. (1973) Striatonigral degeneration: response to levodopa therapy with pathological and neurochemical correlation. J Neurol Sci 19: 275–286.

    PubMed  CAS  Google Scholar 

  • Shy GM, Drager GA (1960) A neurological syndrome associated with orthostatic hypotension: a clinical-pathological study. Arch Neurol 2: 511–527

    PubMed  CAS  Google Scholar 

  • Snyder AM, Strieker EM, Zigmond MJ (1985) stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol 18: 544–551

    PubMed  CAS  Google Scholar 

  • Snyder SH, D’Amato RJ (1986) MPTP: a neurotoxin relevant to the pathophysiology of Parkinson’s disease. Neurology (NY) 36: 250–258

    CAS  Google Scholar 

  • Sobue G, Hashizume Y, Ohya M, Takahashi A (1986) Shy-Drager syndrome: neuronal loss depends on size, function, and topography in ventral spinal outflow. Neurology (NY) 36: 404–407

    CAS  Google Scholar 

  • Soelberg, Sorensen P, Jansen EC, Gjerris F (1986) Motor disturbances in normal-pressure hydrocephalus. Special reference to stance and gait. Arch Neurol 43: 34–38

    Google Scholar 

  • Soffer D, Grotsky HW, Rapin I et al. (1979) Cockayne syndrome: unusual neuropathological findings and review of the literature. Ann Neurol 6: 340–348

    PubMed  CAS  Google Scholar 

  • Spencer PS, Nunn PB, Hugon JS et al. (1987) Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237: 517–522

    PubMed  CAS  Google Scholar 

  • Spitz MC, Jankovic J, Killian JM (1985) Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis—a new syndrome. Neurology (NY) 35: 366–377

    CAS  Google Scholar 

  • Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy: a heterogenous degeneration involving in the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–359

    PubMed  CAS  Google Scholar 

  • Stein RW, Kase CS, Hier DB et al. (1984) Caudate hemorrhage. Neurology (NY) 34: 1549–1554

    CAS  Google Scholar 

  • Stephen PJ, Williamson J (1984) Drug-induced parkinsonism in the elderly. Lancet 2: 1082–1083

    PubMed  CAS  Google Scholar 

  • Strang RR (1966) Parkinsonism occurring during methyldopa therapy. Can Med Assoc J 95: 928–931

    PubMed  CAS  Google Scholar 

  • Takei Y, Mirra SS (1973) Striatonigral degeneration: a form of multiple system atrophy with clinical parkinsonism. Prog Neuropathol 2: 217–251

    Google Scholar 

  • Tarsy D, Baldessarini RJ (1986) Movement disorders induced by psychotherapeutic agents. Clinical features, pathophysiology and management. In: Shah NS, Donald AG (eds) Movement Disorders. Plenum Medical, New York, pp 365–389

    Google Scholar 

  • Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswangens disease. Movement Disorders 2: 1–8

    PubMed  CAS  Google Scholar 

  • Tolosa ES, Santamaria J (1984) Parkinsonism and basal ganglia infarcts. Neurology (NY) 34: 1516–1518.

    CAS  Google Scholar 

  • Uiti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B (1985) Cyanide-induced parkinsonism: a clinicopathologic report. Neurology (NY) 35: 921–925

    Google Scholar 

  • Van der Linden C, Jankovic J, Jansson B (1985) Lateral hypothalamic dysfunction in Parkinson’s disease. Ann Neurol 18: 137–138

    Google Scholar 

  • Van Eck JH (1961) Parkinsonism as a misleading brain tumor syndrome. Psychiatr Neurol Neurochir 64: 109–123

    Google Scholar 

  • Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44: 345–396

    PubMed  CAS  Google Scholar 

  • Ward CD, Duvoisin RC, Ince SE et al. (1983) Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology (NY) 33: 815–824

    CAS  Google Scholar 

  • Weiner HL, de la Monte S (1986) CPC case 25-1986. N Engl J Med 314: 1689–1700

    Google Scholar 

  • Weiner WJ, Nora LM, Glantz RH (1984) Elderly inpatients: postural reflex impairment. Neurology (NY) 34: 945–947

    CAS  Google Scholar 

  • Weir RL, Fan KJ (1981) Spinocerebellar degeneration with parkinsonian features: a clinical and pathological report. Ann Neurol 9: 87–89

    PubMed  CAS  Google Scholar 

  • Whitehouse PJ, Muramoto O, Troncoso JC, Kanazawa I (1986) Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study. Neurology (NY) 36: 193–197

    CAS  Google Scholar 

  • Woods BT, Schaumburg HH (1972) Nigro-spino-dental degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinicopathological entity. J Neurol Sci 17: 149–156

    PubMed  CAS  Google Scholar 

  • Yebenes JG, Gervas JJ, Iglesias J et al. (1982) Biochemical findings in a case of parkinsonism secondary to brain tumor. Ann Neurol 11: 313–316

    Google Scholar 

  • Yebenes JG, Brin MF, Mena MA et al. (1988) Neurochemical findings in neuroacanthocytosis. Movement Disorders 3: 300–312

    PubMed  Google Scholar 

  • Zetusky WJ, Jankovic J, Pirozzolo FJ (1985) The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology (NY) 35: 522–526

    CAS  Google Scholar 

  • Zweig RM, Whitehouse PJ, Casanova MF et al. (1987) Loss of pedunculopontine in progressive supranuclear palsy. Ann Neurol 22: 18–25

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Jankovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Neurology, UBC Health Sciences Centre Hospital, 2211 Wesbrook Mall, Vancouver, British Columbia, Canada, V6T 1W5

    Donald B. Calne Professor D.M., F.R.C.P., F.R.C.P.C. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jankovic, J. (1989). The Relationship Between Parkinson’s Disease and Other Movement Disorders. In: Calne, D.B. (eds) Drugs for the Treatment of Parkinson’s Disease. Handbook of Experimental Pharmacology, vol 88. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73899-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73899-9_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73901-9

  • Online ISBN: 978-3-642-73899-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation